< Return to Video

Is MDMA psychiatry’s antibiotic? | Ben Sessa | TEDxUniversityofBristol

  • 0:16 - 0:29
    3:4 methylenedioxypyrovalerone on drug
  • 0:26 - 0:32
    ecstasy but today I want to talk about
  • 0:29 - 0:35
    MDMA not as a recreational drug but as a
  • 0:32 - 0:37
    potential new treatment in medicine and
  • 0:35 - 0:40
    then very important treatment for
  • 0:37 - 0:42
    psychiatry because MDMA could offer us
  • 0:40 - 0:45
    in psychiatry for the first time the
  • 0:42 - 0:48
    opportunity to tackle trauma and
  • 0:45 - 0:49
    psychological trauma particularly that
  • 0:48 - 0:53
    caused by child abuse and maltreatment
  • 0:49 - 0:56
    is at the heart of all or most
  • 0:53 - 1:00
    psychiatric disorders due to anxiety and
  • 0:56 - 1:03
    addictions psychiatry is in need of this
  • 1:00 - 1:05
    innovative approach because current
  • 1:03 - 1:09
    treatments are failing patients
  • 1:05 - 1:10
    hi my name's Ben sesor I'm a child and
  • 1:09 - 1:12
    adolescent psychiatrist now that means I
  • 1:10 - 1:15
    trained as a medical doctor then
  • 1:12 - 1:16
    specialized in mental health and then
  • 1:15 - 1:18
    specialized in child and adolescent
  • 1:16 - 1:20
    mental health but for the last five
  • 1:18 - 1:22
    years I've been working with adults with
  • 1:20 - 1:25
    mental health disorders and addictions
  • 1:22 - 1:28
    due to misuse of drugs and that
  • 1:25 - 1:30
    developmental pathway of my own from
  • 1:28 - 1:32
    working with child abuse into adults
  • 1:30 - 1:35
    with mental disorders and addictions has
  • 1:32 - 1:37
    brought me to the door of MDMA and I'm
  • 1:35 - 1:39
    gonna propose today that MDMA could be
  • 1:37 - 1:42
    important for the future as the Kyah
  • 1:39 - 1:44
    tree as the discovery of antibiotics was
  • 1:42 - 1:48
    for general medicine a hundred years ago
  • 1:44 - 1:51
    so when we think about child abuse we
  • 1:48 - 1:54
    think about physical abuse mental abuse
  • 1:51 - 1:58
    emotional abuse sexual abuse and neglect
  • 1:54 - 1:59
    and we think about noxious environments
  • 1:58 - 2:01
    we think about parents with mental
  • 1:59 - 2:04
    disorder we think about parents who are
  • 2:01 - 2:07
    addicted to drugs and social issues like
  • 2:04 - 2:09
    poverty and poor housing poor education
  • 2:07 - 2:11
    now I'm going to illustrate my talk
  • 2:09 - 2:12
    today with a patient and I'm going to
  • 2:11 - 2:15
    call her Claire
  • 2:12 - 2:17
    now Claire was no single particular
  • 2:15 - 2:19
    patient of mine rather she's an
  • 2:17 - 2:21
    amalgamation of many different people
  • 2:19 - 2:24
    I've met in the last 18 years working as
  • 2:21 - 2:25
    a medical doctor she's certainly not the
  • 2:24 - 2:28
    worst
  • 2:25 - 2:31
    now what was Claire's environment like
  • 2:28 - 2:32
    she was growing up well her mother was
  • 2:31 - 2:35
    depressed now unfortunately the family
  • 2:32 - 2:37
    doctor didn't have time to accurately
  • 2:35 - 2:39
    diagnose and treat depression rather
  • 2:37 - 2:40
    Claire's mother was put onto one
  • 2:39 - 2:43
    antidepressant after another
  • 2:40 - 2:45
    never really got therapy Claire's mother
  • 2:43 - 2:47
    also had a lot of aches and pains
  • 2:45 - 2:49
    typical what we call psychosomatic
  • 2:47 - 2:52
    symptoms in depression and as a result
  • 2:49 - 2:53
    the family doctor put her on to opiate
  • 2:52 - 2:57
    based painkillers which she promptly
  • 2:53 - 2:59
    became addicted to now Claire's father
  • 2:57 - 3:02
    now he was alcoholic and he was often
  • 2:59 - 3:03
    not around in and out of prison which is
  • 3:02 - 3:05
    just as well because when he was there
  • 3:03 - 3:08
    he was physically abusive to Claire and
  • 3:05 - 3:11
    her mother okay so what does this kind
  • 3:08 - 3:14
    of chaotic frightening environment due
  • 3:11 - 3:16
    to the developing child brain I'm going
  • 3:14 - 3:18
    to give you a brief neurophysiology
  • 3:16 - 3:20
    lesson if I may there's a part of the
  • 3:18 - 3:22
    brain called the amygdala now the
  • 3:20 - 3:24
    amygdala is a very ancient part of the
  • 3:22 - 3:27
    mammalian brain and many other animals
  • 3:24 - 3:29
    other than humans have an amygdala the
  • 3:27 - 3:32
    amygdala lights up when stimulated by
  • 3:29 - 3:34
    fear in the environment by a frightening
  • 3:32 - 3:36
    stimulus if lights up and it says
  • 3:34 - 3:38
    fight-or-flight get out
  • 3:36 - 3:40
    now there's another part of the brain
  • 3:38 - 3:42
    much more sophisticated part called the
  • 3:40 - 3:44
    prefrontal cortex and it's right here at
  • 3:42 - 3:47
    the front above the eyes
  • 3:44 - 3:49
    now the prefrontal cortex only humans
  • 3:47 - 3:52
    have and it's in the prefrontal cortex
  • 3:49 - 3:55
    where we use logic and reasoning to
  • 3:52 - 3:58
    rationalize the situation and we can use
  • 3:55 - 3:59
    our prefrontal cortex to overcome that
  • 3:58 - 4:02
    instinctive fear response from the
  • 3:59 - 4:04
    amygdala now when Claire was growing up
  • 4:02 - 4:06
    she never knew from one moment to the
  • 4:04 - 4:07
    next whether the adult coming into the
  • 4:06 - 4:10
    room were they going to give him a kiss
  • 4:07 - 4:12
    or a cuddle or do a jigsaw with her over
  • 4:10 - 4:14
    they're going to punch her or kick her
  • 4:12 - 4:17
    or burn her with their cigarette or were
  • 4:14 - 4:18
    they going to rape her because
  • 4:17 - 4:24
    throughout her childhood Claire was also
  • 4:18 - 4:26
    subjected to sexual abuse now there's a
  • 4:24 - 4:27
    lupa disorders called the anxiety
  • 4:26 - 4:29
    disorders and one of the most important
  • 4:27 - 4:34
    is what we call post-traumatic stress
  • 4:29 - 4:37
    disorder or PTSD now PTSD some of the
  • 4:34 - 4:40
    core features very low mood anxiety high
  • 4:37 - 4:43
    levels of anxiety what we call hyper
  • 4:40 - 4:46
    vigilance this edginess this jumpiness
  • 4:43 - 4:48
    exactly how claire felt throughout her
  • 4:46 - 4:50
    childhood and adolescence never knowing
  • 4:48 - 4:52
    whether they next assailant or assault
  • 4:50 - 4:55
    was around the corner another core
  • 4:52 - 4:57
    feature of PTSD what we call REE
  • 4:55 - 4:59
    experiencing phenomena flashbacks in
  • 4:57 - 5:01
    which the patient has sudden
  • 4:59 - 5:03
    remembrances of these painful traumatic
  • 5:01 - 5:06
    memories they can just pop into the head
  • 5:03 - 5:09
    at any time triggered by some cue in the
  • 5:06 - 5:11
    environment and when they have those
  • 5:09 - 5:13
    experiences those daytime flashbacks
  • 5:11 - 5:15
    they relive the trauma in all the
  • 5:13 - 5:18
    sensory modalities and this results in
  • 5:15 - 5:21
    them freezing or dissociating to try and
  • 5:18 - 5:22
    block out the pain now Claire
  • 5:21 - 5:27
    experienced all of this as she was
  • 5:22 - 5:30
    growing up high levels of self-harm and
  • 5:27 - 5:32
    suicide are associated with PTSD Claire
  • 5:30 - 5:35
    would cut her thighs and her breasts
  • 5:32 - 5:37
    pretty common form of cutting in
  • 5:35 - 5:39
    children who've been sexually abused she
  • 5:37 - 5:41
    was being sexually abused by clients of
  • 5:39 - 5:44
    her mother because her mother had moved
  • 5:41 - 5:45
    on from the addiction to painkillers and
  • 5:44 - 5:48
    was using street heroin when Claire was
  • 5:45 - 5:50
    a teenager and because of the way the
  • 5:48 - 5:52
    war on drugs has set up that reduces
  • 5:50 - 5:55
    access to treatment for people with
  • 5:52 - 5:57
    opiate dependence she had to pay for her
  • 5:55 - 6:01
    heroin using sex work and the clients
  • 5:57 - 6:04
    would sexually abused Claire now it's
  • 6:01 - 6:07
    very hard to treat PTSD and it has a
  • 6:04 - 6:08
    high treatment resistance 50% of people
  • 6:07 - 6:11
    do not respond to the traditional
  • 6:08 - 6:13
    treatments how do we treat it well we
  • 6:11 - 6:16
    can treat it with medications we can
  • 6:13 - 6:18
    treat it with psychotherapies and the
  • 6:16 - 6:21
    medications we use there's a broad range
  • 6:18 - 6:24
    of drugs no single drug and this is very
  • 6:21 - 6:26
    important no single drug cures PTSD
  • 6:24 - 6:28
    rather we treat the disorder
  • 6:26 - 6:30
    symptomatically if the patient's
  • 6:28 - 6:33
    depressed give them an antidepressant if
  • 6:30 - 6:35
    their mood fluctuates give them a mood
  • 6:33 - 6:36
    stabilizer if they can't sleep
  • 6:35 - 6:38
    give them a hypnotic
  • 6:36 - 6:41
    and if that edginess and that fear
  • 6:38 - 6:43
    spills over into paranoia and psychosis
  • 6:41 - 6:46
    give the patient an anti-psychotic drug
  • 6:43 - 6:48
    and they have to take these drugs day in
  • 6:46 - 6:51
    day out for weeks months decades they
  • 6:48 - 6:54
    have to keep taking them because the
  • 6:51 - 6:56
    drugs we use to treat trauma when it's
  • 6:54 - 6:59
    due to this level of severity do not
  • 6:56 - 7:02
    attack the root cause of trauma they
  • 6:59 - 7:06
    paper over the cracks a good analogy
  • 7:02 - 7:09
    would be taking aspirin or ibuprofen
  • 7:06 - 7:11
    when you have a fever now a fever is
  • 7:09 - 7:14
    caused by an infection by an ant by a
  • 7:11 - 7:17
    microorganism sure you can take powerset
  • 7:14 - 7:18
    amal or ibuprofen and this will lower
  • 7:17 - 7:21
    the temperature and make you feel a bit
  • 7:18 - 7:23
    better but it doesn't attack the root
  • 7:21 - 7:27
    cause and that's what we do when we give
  • 7:23 - 7:29
    these patients these daily SSRI drugs we
  • 7:27 - 7:32
    paper over the cracks we maintain the
  • 7:29 - 7:35
    symptoms at a manageable level we also
  • 7:32 - 7:38
    use psycho therapies to treat PTSD
  • 7:35 - 7:42
    unless again a broad range of these DBT
  • 7:38 - 7:45
    CBT EMDR trauma focused psychotherapy
  • 7:42 - 7:48
    cata PT now all of them have a pretty
  • 7:45 - 7:50
    similar approach which actually is an
  • 7:48 - 7:52
    old wives tales which is a problem
  • 7:50 - 7:55
    shared is a problem halved let's talk
  • 7:52 - 7:59
    about your trauma Claire tell me about
  • 7:55 - 8:02
    your rape now that's fine for 50% of
  • 7:59 - 8:05
    patients but for a significant half they
  • 8:02 - 8:07
    just cannot do that as soon as Claire is
  • 8:05 - 8:10
    asked to talk about her rape she freezes
  • 8:07 - 8:12
    she flees she drops out of treatment now
  • 8:10 - 8:14
    by the time she was 15 Claire had been
  • 8:12 - 8:16
    removed from the family home and she was
  • 8:14 - 8:19
    brought up in a succession of foster
  • 8:16 - 8:21
    placements and children's houses and
  • 8:19 - 8:24
    hostels where the abuse continued and
  • 8:21 - 8:26
    she was self-harm cutting and she
  • 8:24 - 8:29
    started drinking and by the time she was
  • 8:26 - 8:31
    18 she was using heroin as well
  • 8:29 - 8:33
    sometimes working in Skytree can feel
  • 8:31 - 8:35
    pretty desperate can feel pretty
  • 8:33 - 8:37
    hopeless sometimes it feels as if
  • 8:35 - 8:40
    psychiatry is a palliative care
  • 8:37 - 8:42
    profession and this is the truth because
  • 8:40 - 8:44
    the treatments we use do not get to the
  • 8:42 - 8:47
    root cause of the problem the trauma
  • 8:44 - 8:49
    they paper over the cracks and I think
  • 8:47 - 8:50
    the pharma industry know this and they
  • 8:49 - 8:52
    queue up and they
  • 8:50 - 8:54
    provide us with product after product to
  • 8:52 - 8:56
    give to our patients that doesn't quite
  • 8:54 - 8:59
    cure them but it gets them slightly
  • 8:56 - 9:01
    better to function and they have to keep
  • 8:59 - 9:03
    taking them indeed I would say that we
  • 9:01 - 9:05
    are in psychiatry today where we were in
  • 9:03 - 9:07
    general medicine 100 years ago now 100
  • 9:05 - 9:09
    years ago in general medicine humanity
  • 9:07 - 9:11
    was losing the battle to the infectious
  • 9:09 - 9:13
    diseases oh we were very good at
  • 9:11 - 9:16
    classifying and diagnosing them we knew
  • 9:13 - 9:18
    who got smallpox we knew people died of
  • 9:16 - 9:20
    post-operative surgery we knew there
  • 9:18 - 9:22
    were microorganisms but we didn't have a
  • 9:20 - 9:24
    treatment and then at the beginning of
  • 9:22 - 9:27
    the 20th century we discovered the
  • 9:24 - 9:29
    antibiotics not symptomatic treatment
  • 9:27 - 9:32
    but treatment that goes to the core of
  • 9:29 - 9:35
    the cause and we started getting on top
  • 9:32 - 9:38
    of infectious disease now psychiatry
  • 9:35 - 9:40
    today is in a similar place we're very
  • 9:38 - 9:42
    good at classifying and diagnosing our
  • 9:40 - 9:45
    epidemiology is superb we write these
  • 9:42 - 9:47
    thick diagnostic manuals we know who
  • 9:45 - 9:50
    gets depression we know who gets anxiety
  • 9:47 - 9:53
    we even know the cause trauma child
  • 9:50 - 9:55
    abuse maltreatment poor social
  • 9:53 - 10:01
    conditions but our treatments are lousy
  • 9:55 - 10:03
    and I'm quite shocked away the empathy
  • 10:01 - 10:06
    switch and our understanding of these
  • 10:03 - 10:08
    patients seems to be switched off we
  • 10:06 - 10:10
    have lots of gushing sentimentality for
  • 10:08 - 10:12
    the little five and six year old who's
  • 10:10 - 10:15
    being abused and we throw money at our
  • 10:12 - 10:17
    television sets on these campaigns to
  • 10:15 - 10:19
    improve the lives of these poor little
  • 10:17 - 10:20
    innocent victims well let me tell you
  • 10:19 - 10:24
    what happens to that little five or six
  • 10:20 - 10:27
    year old when they're 11 or 12 on goes
  • 10:24 - 10:29
    the hood start smoking weed by the time
  • 10:27 - 10:30
    they're 16 they're buying and selling
  • 10:29 - 10:32
    amphetamine and by the time they're
  • 10:30 - 10:34
    Claire's age in their mid-20s they're
  • 10:32 - 10:37
    addicted to heroin and alcohol and
  • 10:34 - 10:40
    suddenly we have lost our empathy these
  • 10:37 - 10:42
    people are public enemy number one it's
  • 10:40 - 10:45
    your fault Claire you brought this upon
  • 10:42 - 10:47
    yourself it's your lifestyle choice and
  • 10:45 - 10:51
    I'm quite shocked and having worked in
  • 10:47 - 10:53
    Pediatrics and seen the developmental
  • 10:51 - 10:56
    trajectory that is so inevitable from
  • 10:53 - 10:58
    early trauma into adolescent and then
  • 10:56 - 10:59
    adult mental health and addictions we
  • 10:58 - 11:01
    have to hold on to that sense of
  • 10:59 - 11:02
    compassion and evidence-based
  • 11:01 - 11:05
    understanding
  • 11:02 - 11:08
    about the developmental trajectory there
  • 11:05 - 11:10
    so it does sound desperate but all is
  • 11:08 - 11:10
    not lost
  • 11:10 - 11:17
    MDMA MDMA has some fascinating qualities
  • 11:14 - 11:19
    indeed I would suggest that if you were
  • 11:17 - 11:22
    to invent a hypothetical drug to treat
  • 11:19 - 11:24
    chorma it would be MDMA the way it works
  • 11:22 - 11:26
    in terms of its receptors and it's
  • 11:24 - 11:28
    subjective psychological effects ticks
  • 11:26 - 11:31
    all the right boxes at one level of
  • 11:28 - 11:33
    receptors it causes a increased positive
  • 11:31 - 11:36
    mood lowering of depression lowering of
  • 11:33 - 11:38
    anxiety at another group of receptors it
  • 11:36 - 11:40
    speeds the patient up mild stimulation
  • 11:38 - 11:44
    which motivates them to engage in
  • 11:40 - 11:46
    therapy at another level it would Laxus
  • 11:44 - 11:48
    the patient paradoxically at the same
  • 11:46 - 11:50
    time as the stimulation and this puts
  • 11:48 - 11:52
    the patient into the optimal arousal
  • 11:50 - 11:54
    zone where they can engage in
  • 11:52 - 11:57
    psychotherapy but perhaps the most
  • 11:54 - 11:59
    important thing about MDMA and the most
  • 11:57 - 12:02
    important clinical tool is its ability
  • 11:59 - 12:07
    to provide a sense of empathy and
  • 12:02 - 12:10
    understanding and emotional security it
  • 12:07 - 12:12
    can hold the patient in a place where
  • 12:10 - 12:14
    they can think about and access their
  • 12:12 - 12:17
    trauma like they've never been able to
  • 12:14 - 12:20
    do before one of the ways in which MDMA
  • 12:17 - 12:23
    works is it increases the release of a
  • 12:20 - 12:24
    hormone called oxytocin now oxytocin is
  • 12:23 - 12:26
    released from the brains of
  • 12:24 - 12:28
    breastfeeding mothers it's a hormone
  • 12:26 - 12:30
    that engenders a sense of attachment and
  • 12:28 - 12:34
    bonding and that's what's happening in
  • 12:30 - 12:36
    the patient who takes MDMA and also it
  • 12:34 - 12:39
    acts directly on the amygdala to reduce
  • 12:36 - 12:41
    that fear response whilst at the same
  • 12:39 - 12:43
    time boosting the prefrontal response
  • 12:41 - 12:47
    allowing the patient to see things in a
  • 12:43 - 12:51
    new light a positive light so let's go
  • 12:47 - 12:52
    back to Claire she's 40 now she's been
  • 12:51 - 12:54
    in and out of psychiatric hospitals
  • 12:52 - 12:56
    having tried to take her own life and
  • 12:54 - 12:58
    the inception she's been on all the
  • 12:56 - 13:00
    antipsychotic antidepressant mood
  • 12:58 - 13:02
    stabiliser drugs she's tried all the
  • 13:00 - 13:04
    psychotherapies but she cannot engage
  • 13:02 - 13:09
    because she will not talk about her
  • 13:04 - 13:11
    feelings so she comes into a course of
  • 13:09 - 13:14
    mdma-assisted psychotherapy
  • 13:11 - 13:16
    what does it look like well
  • 13:14 - 13:19
    it's weekly sessions maybe eight ten
  • 13:16 - 13:23
    twelve weeks long the two therapists
  • 13:19 - 13:25
    male-female pair you do not take MDMA
  • 13:23 - 13:27
    everyday you do not take it every every
  • 13:25 - 13:29
    week over that course of 12 sessions
  • 13:27 - 13:31
    you'll take the MDMA three times and the
  • 13:29 - 13:34
    other sessions you talk about the
  • 13:31 - 13:37
    material that's released on the MDMA
  • 13:34 - 13:41
    session so what does Claire actually
  • 13:37 - 13:43
    feel when she takes this MDMA what she
  • 13:41 - 13:46
    feels is a sense of warmth and
  • 13:43 - 13:49
    understanding and a sense of containment
  • 13:46 - 13:52
    within that relationship she's having
  • 13:49 - 13:55
    with the therapist MDMA is like it's
  • 13:52 - 13:58
    like a lifejacket like a bulletproof
  • 13:55 - 14:02
    vest to wear to go into battle with your
  • 13:58 - 14:05
    trauma this is not ecstasy she's not
  • 14:02 - 14:07
    enjoying some ravers euphoric ecstasy
  • 14:05 - 14:10
    delight this is still trauma focused
  • 14:07 - 14:12
    psychotherapy and it is still hard and
  • 14:10 - 14:15
    distressing for her but she can just
  • 14:12 - 14:18
    about do it with MDMA on board so when
  • 14:15 - 14:21
    the therapist says Claire tell me about
  • 14:18 - 14:23
    your rape now in the past just the word
  • 14:21 - 14:26
    rape and she'd be out the door but on
  • 14:23 - 14:29
    MDMA she says yeah I can talk about that
  • 14:26 - 14:32
    I can see him now coming into the room I
  • 14:29 - 14:34
    can smell the whiskey on his breath and
  • 14:32 - 14:37
    I can feel the stubble on his face as
  • 14:34 - 14:39
    he's raping me and she talks about it
  • 14:37 - 14:42
    and she explores it and she reflects
  • 14:39 - 14:45
    upon it and she can begin the process of
  • 14:42 - 14:48
    healing and from here she can start her
  • 14:45 - 14:51
    journey she can attack the root cause of
  • 14:48 - 14:57
    her problems not just maintain the
  • 14:51 - 14:59
    symptoms at a level so does it work well
  • 14:57 - 15:01
    we've known about MDMA for very long
  • 14:59 - 15:04
    time and indeed we've used MDMA in
  • 15:01 - 15:06
    underground therapy for 30 or 40 years
  • 15:04 - 15:09
    and there are thousands of positive
  • 15:06 - 15:12
    anecdotal cases I get five emails a week
  • 15:09 - 15:14
    from all over the world dr. sesor I've
  • 15:12 - 15:16
    had PTSD for years I've tried everything
  • 15:14 - 15:17
    and now I tried MDMA and I'm starting to
  • 15:16 - 15:20
    make a breakthrough
  • 15:17 - 15:22
    now anecdotal reports like that are
  • 15:20 - 15:23
    interesting but they're not science so
  • 15:22 - 15:26
    we've done the science and some
  • 15:23 - 15:27
    important studies in recent years big
  • 15:26 - 15:30
    study in the state
  • 15:27 - 15:33
    showed that a single course of MDMA
  • 15:30 - 15:35
    therapy 16-week quarks patient takes
  • 15:33 - 15:39
    MDMA three times tested against a
  • 15:35 - 15:42
    placebo at the end of that course 85% of
  • 15:39 - 15:45
    the people no longer met the diagnostic
  • 15:42 - 15:48
    criteria for PTSD not just a relief of
  • 15:45 - 15:50
    symptoms they didn't have PTSD
  • 15:48 - 15:54
    now that cohort were then followed up
  • 15:50 - 15:57
    three years later the same no PTSD many
  • 15:54 - 16:01
    of those people had come off their daily
  • 15:57 - 16:04
    medications they were cured we don't use
  • 16:01 - 16:08
    the Cure word in psychiatry we've become
  • 16:04 - 16:10
    learned helplessness position of this is
  • 16:08 - 16:12
    the truth if you're diagnosed with a
  • 16:10 - 16:13
    severe mental disorder like anxiety or
  • 16:12 - 16:15
    depression in your 20s and the
  • 16:13 - 16:18
    developmental route of that disorder is
  • 16:15 - 16:20
    severe child abuse there's a pretty good
  • 16:18 - 16:22
    chance and I'm sorry to say this there's
  • 16:20 - 16:24
    a pretty good chance you will still be
  • 16:22 - 16:27
    going to psychiatric clinics in your 60s
  • 16:24 - 16:29
    and 70s now that is not good enough and
  • 16:27 - 16:33
    we're in this position because we're not
  • 16:29 - 16:37
    tackling trauma so it works but is it
  • 16:33 - 16:40
    safe well we're anything about safety of
  • 16:37 - 16:43
    clinical MDMA what we must not do is
  • 16:40 - 16:46
    look at the risks of recreational
  • 16:43 - 16:47
    ecstasy I don't even know what ecstasy
  • 16:46 - 16:49
    is anymore
  • 16:47 - 16:52
    ecstasy is over here what is ecstasy
  • 16:49 - 16:54
    some dodgy pill bought in some dodgy
  • 16:52 - 16:57
    club or some dodgy geezer that may or
  • 16:54 - 17:00
    may not contain MDMA plus or minus
  • 16:57 - 17:03
    whatever far more toxic substance and
  • 17:00 - 17:05
    indeed when you hear about the very
  • 17:03 - 17:10
    high-profile deaths of people who take
  • 17:05 - 17:12
    ecstasy it invariably is not MDMA so
  • 17:10 - 17:15
    let's not look at ecstasy as a measure
  • 17:12 - 17:18
    of MDMA let's look at clinical MDMA now
  • 17:15 - 17:21
    when will you use clinical MDMA you take
  • 17:18 - 17:23
    it under medical supervision it is pure
  • 17:21 - 17:30
    the MDMA that I'm using in my studies is
  • 17:23 - 17:33
    99.98% pure very expensive
  • 17:30 - 17:34
    we do it under medical supervision with
  • 17:33 - 17:38
    a doctor and a nurse and a psychologist
  • 17:34 - 17:41
    and under those conditions the risks are
  • 17:38 - 17:43
    reduced to a absolute minimum indeed
  • 17:41 - 17:46
    after 40 years of MDMA research there
  • 17:43 - 17:49
    has not been a single serious adverse
  • 17:46 - 17:54
    drug reaction not one and certainly no
  • 17:49 - 17:56
    deaths so we need to do this research
  • 17:54 - 18:00
    and we need to do this research in an
  • 17:56 - 18:03
    evidence-based compassionate way looking
  • 18:00 - 18:05
    at the data we need to ignore the
  • 18:03 - 18:07
    socio-political agenda that says any
  • 18:05 - 18:12
    drug that's being used recreationally
  • 18:07 - 18:16
    must also be very bad and dangerous that
  • 18:12 - 18:19
    sort of attitude hampers research and we
  • 18:16 - 18:22
    need scientists to drive this it works
  • 18:19 - 18:24
    it's safe and it offers patients like
  • 18:22 - 18:26
    Claire for the first time in their life
  • 18:24 - 18:28
    an opportunity to break through from
  • 18:26 - 18:31
    that trauma and not become a lifelong
  • 18:28 - 18:33
    chronic PTSD sufferer so where were we
  • 18:31 - 18:35
    going with MDMA research well we've had
  • 18:33 - 18:37
    some studies we've got more coming here
  • 18:35 - 18:39
    I'm doing a study in Cardiff with
  • 18:37 - 18:42
    neuroimaging in which we're going to
  • 18:39 - 18:43
    give patients with PTSD MDMA and placebo
  • 18:42 - 18:45
    and we're going to look at that Plus
  • 18:43 - 18:48
    that the relationship between the
  • 18:45 - 18:49
    amygdala and the prefrontal cortex we're
  • 18:48 - 18:51
    also doing a study here in Bristol
  • 18:49 - 18:55
    giving patients with alcohol use
  • 18:51 - 18:58
    disorder MDMA because underlying the
  • 18:55 - 19:01
    root of this addiction is trauma so this
  • 18:58 - 19:02
    is an exciting time now people say this
  • 19:01 - 19:04
    is controversial and indeed that was
  • 19:02 - 19:06
    introduced as a controversial speaker
  • 19:04 - 19:09
    I'm not controversial I'm a very boring
  • 19:06 - 19:12
    conservative doctor I like data
  • 19:09 - 19:14
    I like evidence-based data that helps my
  • 19:12 - 19:17
    patients I'll tell you what's
  • 19:14 - 19:19
    controversial what's controversial is
  • 19:17 - 19:21
    that more people have died returning
  • 19:19 - 19:23
    from Afghanistan and Iraq because
  • 19:21 - 19:26
    they've committed suicide because of
  • 19:23 - 19:28
    their untreated PTSD then ever died in
  • 19:26 - 19:33
    the conflict out there that is
  • 19:28 - 19:35
    controversial and that is unethical so
  • 19:33 - 19:38
    this is a important time for science
  • 19:35 - 19:41
    MDMA could be the antibiotic that
  • 19:38 - 19:42
    psychiatry has been waiting for we owe
  • 19:41 - 19:44
    that population of patients who are
  • 19:42 - 19:47
    being failed
  • 19:44 - 19:50
    we owe them this research we owe this
  • 19:47 - 19:50
    declare thank you
Title:
Is MDMA psychiatry’s antibiotic? | Ben Sessa | TEDxUniversityofBristol
Description:

more » « less
Video Language:
English
Team:
closed TED
Project:
TEDxTalks
Duration:
19:59

English subtitles

Revisions Compare revisions